S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Bear market expert makes new prediction (Ad)
UK travelers face hours-long waits for ferries to France
'War of the states': EV, chip makers lavished with subsidies
BREAKING: Tiny biotech successfully treats blindness (Ad)
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
BREAKING: Tiny biotech successfully treats blindness (Ad)
Shipbuilder Austal executives accused of inflating earnings
No more room for vroom? Paris votes on banishing e-scooters
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Bear market expert makes new prediction (Ad)
UK travelers face hours-long waits for ferries to France
'War of the states': EV, chip makers lavished with subsidies
BREAKING: Tiny biotech successfully treats blindness (Ad)
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
BREAKING: Tiny biotech successfully treats blindness (Ad)
Shipbuilder Austal executives accused of inflating earnings
No more room for vroom? Paris votes on banishing e-scooters
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Bear market expert makes new prediction (Ad)
UK travelers face hours-long waits for ferries to France
'War of the states': EV, chip makers lavished with subsidies
BREAKING: Tiny biotech successfully treats blindness (Ad)
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
BREAKING: Tiny biotech successfully treats blindness (Ad)
Shipbuilder Austal executives accused of inflating earnings
No more room for vroom? Paris votes on banishing e-scooters
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Bear market expert makes new prediction (Ad)
UK travelers face hours-long waits for ferries to France
'War of the states': EV, chip makers lavished with subsidies
BREAKING: Tiny biotech successfully treats blindness (Ad)
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
BREAKING: Tiny biotech successfully treats blindness (Ad)
Shipbuilder Austal executives accused of inflating earnings
No more room for vroom? Paris votes on banishing e-scooters
NASDAQ:MTLS

Materialise - MTLS Stock Forecast, Price & News

$8.30
+0.25 (+3.11%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$8.07
$8.32
50-Day Range
$7.45
$11.25
52-Week Range
$7.30
$21.50
Volume
64,878 shs
Average Volume
152,580 shs
Market Capitalization
$490.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.00

Materialise MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
116.9% Upside
$18.00 Price Target
Short Interest
Healthy
0.54% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.62 out of 5 stars

Computer And Technology Sector

531st out of 608 stocks

Prepackaged Software Industry

184th out of 210 stocks


MTLS stock logo

About Materialise (NASDAQ:MTLS) Stock

Materialise NV is engaged in the provision of additive manufacturing software and 3D printing services. It operates through the following segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software worldwide through programs and platforms that enable companies to set up reliable and sustainable 3D printing production. The Materialise Medical segment includes medical software solutions, medical devices and other related products and services. The Materialise Manufacturing segment provides 3D printed services to industrial and commercial customers. The company was founded by Wilfried Vancraen and Hilde Ingelaere on June 28, 1990 and is headquartered in Leuven, Belgium.

Receive MTLS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Materialise and its competitors with MarketBeat's FREE daily newsletter.

MTLS Stock News Headlines

"Prepare for Five Years of Famine"
Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast.
Why Materialise Stock Was Falling on Tuesday
Earnings Preview For Materialise
"Prepare for Five Years of Famine"
Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast.
Materialise Reports Third Quarter 2022 Results
Materialise (MTLS) Matches Q3 Earnings Estimates
See More Headlines
Receive MTLS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Materialise and its competitors with MarketBeat's FREE daily newsletter.

MTLS Company Calendar

Last Earnings
2/14/2023
Today
4/01/2023
Next Earnings (Estimated)
4/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:MTLS
Employees
2,332
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$18.00
High Stock Price Forecast
$22.00
Low Stock Price Forecast
$14.00
Forecasted Upside/Downside
+116.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-2,240,000.00
Pretax Margin
-0.51%

Debt

Sales & Book Value

Annual Sales
$242.81 million
Cash Flow
$0.38 per share
Book Value
$4.08 per share

Miscellaneous

Free Float
58,338,000
Market Cap
$490.20 million
Optionable
Not Optionable
Beta
0.80

Key Executives

  • Wilfried Vancraen
    Chief Executive Officer & Director
  • Johan Pauwels
    Chief Operating Officer & Executive Vice President
  • Johan Albrecht
    Chief Financial Officer & Executive Vice President
  • Hilde Ingelaere
    Director & Executive Vice President-Medical
  • Bart van der Schueren
    Chief Technology Officer & Executive VP













MTLS Stock - Frequently Asked Questions

Should I buy or sell Materialise stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Materialise in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" MTLS shares.
View MTLS analyst ratings
or view top-rated stocks.

What is Materialise's stock price forecast for 2023?

1 analysts have issued 12 month price objectives for Materialise's shares. Their MTLS share price forecasts range from $14.00 to $22.00. On average, they expect the company's share price to reach $18.00 in the next year. This suggests a possible upside of 116.9% from the stock's current price.
View analysts price targets for MTLS
or view top-rated stocks among Wall Street analysts.

How have MTLS shares performed in 2023?

Materialise's stock was trading at $8.80 on January 1st, 2023. Since then, MTLS shares have decreased by 5.7% and is now trading at $8.30.
View the best growth stocks for 2023 here
.

When is Materialise's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 27th 2023.
View our MTLS earnings forecast
.

How were Materialise's earnings last quarter?

Materialise NV (NASDAQ:MTLS) released its quarterly earnings results on Tuesday, February, 14th. The software maker reported ($0.08) earnings per share for the quarter, missing the consensus estimate of $0.04 by $0.12. The software maker earned $66.88 million during the quarter, compared to analyst estimates of $64.55 million. Materialise had a negative trailing twelve-month return on equity of 0.97% and a negative net margin of 0.99%.

What guidance has Materialise issued on next quarter's earnings?

Materialise updated its FY 2023 earnings guidance on Tuesday, February, 14th. The company provided EPS guidance of for the period. The company issued revenue guidance of $260.28 million-$265.38 million, compared to the consensus revenue estimate of $275.42 million.

What is Wilfried Vancraen's approval rating as Materialise's CEO?

52 employees have rated Materialise Chief Executive Officer Wilfried Vancraen on Glassdoor.com. Wilfried Vancraen has an approval rating of 77% among the company's employees.

What other stocks do shareholders of Materialise own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Materialise investors own include NVIDIA (NVDA), Block (SQ), Advanced Micro Devices (AMD), Alibaba Group (BABA), Micron Technology (MU), Gilead Sciences (GILD), Tesla (TSLA), DocuSign (DOCU), Stratasys (SSYS) and 3D Systems (DDD).

What is Materialise's stock symbol?

Materialise trades on the NASDAQ under the ticker symbol "MTLS."

How do I buy shares of Materialise?

Shares of MTLS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Materialise's stock price today?

One share of MTLS stock can currently be purchased for approximately $8.30.

How much money does Materialise make?

Materialise (NASDAQ:MTLS) has a market capitalization of $490.20 million and generates $242.81 million in revenue each year. The software maker earns $-2,240,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis.

How many employees does Materialise have?

The company employs 2,332 workers across the globe.

How can I contact Materialise?

Materialise's mailing address is TECHNOLOGIELAAN 15, LEVUEN C9, 3001. The official website for the company is www.materialise.com. The software maker can be reached via phone at (321) 639-6611, via email at investors@materialise.com, or via fax at 321-639-6600.

This page (NASDAQ:MTLS) was last updated on 4/2/2023 by MarketBeat.com Staff